Bailard’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-39,998
Closed -$33K 720
2022
Q3
$33K Buy
+39,998
New +$33K ﹤0.01% 654